Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-01-28Clinical Trial Update: Postoperative Atrial Fibrillation and Long-term Survival
A completed clinical trial update investigating postoperative atrial fibrillation and its association with long-term survival, including out…
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology [NA]
This clinical trial assessed aspirin and clopidogrel therapy with the WATCHMAN left atrial appendage closure device in patients with atrial …
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation [Phase 3]
Phase 3 trial of the THERMOCOOL SMARTTOUCH catheter for symptomatic paroxysmal atrial fibrillation has completed and posted results in 2015.
-
FDA approval · 2015-01-26FDA Approved: BREVIBLOC — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Brevibloc (esmolol hydrochloride) submitted by Baxter Healthcare Corporation.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation [Phase 2]
Phase 2 dose-finding trial of DU-176b in non-valvular atrial fibrillation has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial Fibrillation [Phase 2]
Late Phase 2 study of DU-176b in non-valvular atrial fibrillation completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
Observational study of the NAVISTAR ThermoCool SF Catheter in atrial fibrillation and paroxysmal arrhythmias has completed, with results pos…
-
CLINICAL_TRIALS research · 2015-01-21Clinical Trial Update: Pharmacogenetics of Warfarin in Puerto Ricans.
A completed clinical trial update examining the pharmacogenetics of warfarin in Puerto Rican participants and its implications for dosing in…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects [Phase 3]
A Phase 3 study evaluated intravenous tedisamil for rapidly converting atrial fibrillation or atrial flutter to normal sinus rhythm in femal…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects [Phase 3]
Phase 3 trial update showing completion of a study evaluating intravenous tedisamil for rapidly converting atrial fibrillation or flutter to…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects [Phase 3]
This update reports the completion of a Phase 3 trial evaluating intravenous tedisamil for the rapid conversion of atrial fibrillation or at…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation [Phase 4]
The CACAF2 study evaluating catheter ablation for cure of atrial fibrillation in Phase 4 was terminated, with results posted in January 2015…
-
CLINICAL_TRIALS other · 2015-01-08Clinical Trial Update: Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention [Phase 4]
Phase 4 clinical trial update on rivaroxaban for patients with atrial fibrillation and coronary artery disease undergoing percutaneous coron…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Paroxysmal Atrial Fibrillation: Role of Inflammation, Oxidative Stress Injury and Effect of Statins [Phase 2]
Phase 2 clinical trial investigating the role of inflammation and oxidative stress in paroxysmal atrial fibrillation and assessing the effec…
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: BAY59-7939 Japanese in Atrial Fibrillation (2nd) [Phase 2]
Phase 2 trial update of BAY59-7939 in Japanese patients with atrial fibrillation; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: BAY59-7939 in Atrial Fibrillation Once Daily (OD) [Phase 2]
Phase 2 trial of BAY59-7939 for atrial fibrillation has completed; no efficacy or safety results are provided in the update.
-
CLINICAL_TRIALS trial_result · 2014-12-25Clinical Trial Update: BAY59-7939, Japanese Phase II in Atrial FibrillationTrial Status [Phase 2]
This update notes the completion of a Phase II clinical trial of BAY59-7939 for atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Retrospective Registry Providing Baseline Data on the Outcome of Left Atrial (LA) or LA Appendage (LAA) Thrombus in Patients With Nonvalvular Atrial Fibrillation (AF) or Atrial Flutter After Standard of Care (SoC) Anticoagulant Therapy
A Bayer-sponsored retrospective registry provides baseline data on the outcome of left atrial (LA) or left atrial appendage (LAA) thrombus i…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Follow up of Radiofrequency Maze in Mitral Patients
This document reports the completion and follow-up of a trial evaluating radiofrequency maze ablation in patients with atrial fibrillation.
-
FDA approval · 2014-12-21FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for amiodarone hydrochloride submitted by Sun Pharmaceutical Industries, signifying a regulatory…
-
FDA approval · 2014-12-21FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for amiodarone hydrochloride from Sun Pharmaceutical Industries, Inc., indicating regulatory approva…
-
CLINICAL_TRIALS trial_result · 2014-12-16Clinical Trial Update: Ten-year Outcomes After AF Ablation
This update reports ten-year outcomes from patients who underwent ablation for atrial fibrillation, summarizing long-term effectiveness and …
-
CLINICAL_TRIALS withdrawal · 2014-12-16Clinical Trial Update: Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation [Phase 4]
A Phase 4 clinical trial evaluating catheter ablation for recently diagnosed paroxysmal atrial fibrillation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-12-12Clinical Trial Update: Anticoagulation in AF Ablation and Effects on Neurocognitive Function [Phase 4]
This Phase 4 trial investigating anticoagulation in atrial fibrillation patients undergoing ablation and its effects on neurocognitive funct…
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: QT Variability Pre and Post Cardioversion
This update reports on a completed clinical trial examining QT variability before and after cardioversion in atrial fibrillation.